Examples of amyloid-negative (left) and amyloid-positive (right) positron emission tomography (PET) scans. In this figure, the amyloid-PET ligand [18F]AZD4694 is shown. The hotter colours indicate more amyloid-PET tracer binding, and colder colours indicate low amyloid-PET tracer binding. The prototypical amyloid-positive PET pattern is of elevated amyloid in the brain’s posterior cingulate cortex, prefrontal cortex, as well as lateral parietal and temporal cortices. These regions display minimal tracer uptake in the amyloid-negative case (left), who has low binding across the whole cerebral cortex. Finally, it is important to note that amyloid-PET tracers have some binding to white matter, which explains the small amounts of hotter colours in the amyloid-negative case.

More information on amyloid-PET visual reads can be found in Johnson KA, Minoshima S, Bohnen NI, et al. “Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association”. Alzheimers Dement. 2013;54(3):476-490

file_download Download in HQ

Related content

image Image Stroke, migraine, AD and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Highlights from the Global Burden of Disease 2021 Study

Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021

25.07.2024 Alzheimer’s Disease
description Article
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.

09.07.2024 Alzheimer’s Disease
grid_view Slide Deck
Alzheimer’s disease – History, definitions and diagnosis

Dementia is an umbrella term used to describe a state where an individual has lost the ability to carry out daily life activities independently because of cognitive impairment that is not due to an underlying psychiatric condition. Alzheimer’s disease (AD) refers to the abnormal presence of Aβ and tau proteins, which define AD among many other neurodegenerative diseases. Dementia -including dementia due to AD- is likely to be underestimated because of underdiagnosis and misdiagnosis.

15.12.2023 Alzheimer’s Disease